Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Appointed director
Acq. announced
|
|
OPTIMER PHARMACEUTICALS INC (OPTR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/17/2015 |
SC 13G/A
| Flynn James E reports a 0% stake in Optimer Pharmaceuticals, Inc. |
| 11/04/2013 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 10/30/2013 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 10/28/2013 |
4
| Schaum Meredith (Gen Counsel and Chief Comp Off) has filed a Form 4 on OPTIMER PHARMACEUTICALS INC|
Txns:
| Disposed/sold 2,937 shares
@ $10.75, valued at
$31.6k
Disposed/sold 30,000 options to buy
@ $10.72, valued at
$321.6k
|
|
| 10/28/2013 |
4
| Sirota Eric (COO) has filed a Form 4 on OPTIMER PHARMACEUTICALS INC|
Txns:
| Disposed/sold 2,129 shares
@ $10.75, valued at
$22.9k
Disposed/sold 10,000 shares
@ $10.75, valued at
$107.5k
|
|
| 10/28/2013 |
4
| AMPER LINDA E (SVP, Human Resources) has filed a Form 4 on OPTIMER PHARMACEUTICALS INC |
| 10/28/2013 |
4
| Webster Stephen W (CFO) has filed a Form 4 on OPTIMER PHARMACEUTICALS INC |
| 10/28/2013 |
4
| Gorbach MD Sherwood (SVP, Chief Scientific Officer) has filed a Form 4 on OPTIMER PHARMACEUTICALS INC|
Txns:
| Disposed/sold 39,886 shares
@ $10.75, valued at
$428.8k
Disposed/sold 2,333 shares
@ $10.75, valued at
$25.1k
Disposed/sold 1,298 options to buy
@ $1.08, valued at
$1.4k
Disposed/sold 11,610 options to buy
@ $1.08, valued at
$12.5k
Disposed/sold 7,500 options to buy
@ $6.9, valued at
$51.8k
Disposed/sold 100,000 options to buy
@ $6.59, valued at
$659k
Disposed/sold 12,000 options to buy
@ $11.85, valued at
$142.2k
Disposed/sold 20,000 options to buy
@ $9.03, valued at
$180.6k
Disposed/sold 40,000 options to buy
@ $11.41, valued at
$456.4k
Disposed/sold 60,000 options to buy
@ $10.72, valued at
$643.2k
|
|
| 10/28/2013 |
4
| MCKINNELL HENRY A (CEO and Chairman of the Board) has filed a Form 4 on OPTIMER PHARMACEUTICALS INC|
Txns:
| Disposed/sold 10,000 shares
@ $10.75, valued at
$107.5k
Disposed/sold 15,000 shares
@ $10.75, valued at
$161.3k
Disposed/sold 20,000 options to buy
@ $11.67, valued at
$233.4k
Disposed/sold 10,000 options to buy
@ $11.67, valued at
$116.7k
Disposed/sold 225,000 options to buy
@ $10.72, valued at
$2.4M
|
|
| 10/28/2013 |
4
| Newman Stephen L (Director) has filed a Form 4 on OPTIMER PHARMACEUTICALS INC|
Txns:
| Disposed/sold 7,500 shares
@ $10.75, valued at
$80.6k
|
|
| 10/28/2013 |
4
| GREBOW PETER E (Director) has filed a Form 4 on OPTIMER PHARMACEUTICALS INC|
Txns:
| Disposed/sold 7,500 shares
@ $10.75, valued at
$80.6k
Disposed/sold 10,000 options to buy
@ $10.85, valued at
$108.5k
Disposed/sold 5,000 options to buy
@ $10.85, valued at
$54.3k
Disposed/sold 10,000 options to buy
@ $11.85, valued at
$118.5k
Disposed/sold 10,000 options to buy
@ $9.56, valued at
$95.6k
|
|
| 10/28/2013 |
4
| ZERBE ROBERT L MD (Director) has filed a Form 4 on OPTIMER PHARMACEUTICALS INC|
Txns:
| Disposed/sold 7,500 shares
@ $10.75, valued at
$80.6k
Disposed/sold 10,000 options to buy
@ $10.9, valued at
$109k
Disposed/sold 10,000 options to buy
@ $11.85, valued at
$118.5k
Disposed/sold 10,000 options to buy
@ $9.56, valued at
$95.6k
|
|
| 10/28/2013 |
4
| AUERBACH MARK (Director) has filed a Form 4 on OPTIMER PHARMACEUTICALS INC |
| 10/28/2013 |
4
| Chang Michael N (Director) has filed a Form 4 on OPTIMER PHARMACEUTICALS INC|
Txns:
| Disposed/sold 1,026,956 shares
@ $10.75, valued at
$11M
Disposed/sold 441,761 shares
@ $10.75, valued at
$4.7M
Disposed/sold 80,000 options to buy
@ $10.75, valued at
$860k
Disposed/sold 80,000 options to buy
@ $11.85, valued at
$948k
Disposed/sold 2,000 options to buy
@ $9.56, valued at
$19.1k
Disposed/sold 30,000 options to buy
@ $11.85, valued at
$355.5k
Disposed/sold 11,000 options to buy
@ $11.41, valued at
$125.5k
|
|
| 10/28/2013 |
4
| CHANG JOSEPH Y (Director) has filed a Form 4 on OPTIMER PHARMACEUTICALS INC|
Txns:
| Disposed/sold 10,000 shares
@ $10.75, valued at
$107.5k
Disposed/sold 7,500 shares
@ $10.75, valued at
$80.6k
Disposed/sold 46,154 shares
@ $10.75, valued at
$496.2k
Disposed/sold 3,461 options to buy
@ $1.08, valued at
$3.7k
Disposed/sold 3,461 options to buy
@ $2.17, valued at
$7.5k
Disposed/sold 5,000 options to buy
@ $7.1, valued at
$35.5k
Disposed/sold 5,000 options to buy
@ $10.75, valued at
$53.8k
Disposed/sold 10,000 options to buy
@ $11.85, valued at
$118.5k
Disposed/sold 10,000 options to buy
@ $9.56, valued at
$95.6k
|
|
| 10/25/2013 |
4
| ALTIG ANTHONY E (Director) has filed a Form 4 on OPTIMER PHARMACEUTICALS INC|
Txns:
| Disposed/sold 5,000 shares
@ $10.75, valued at
$53.8k
Disposed/sold 7,500 shares
@ $10.75, valued at
$80.6k
Disposed/sold 5,000 options to buy
@ $7.1, valued at
$35.5k
Disposed/sold 10,000 options to buy
@ $7.1, valued at
$71k
Disposed/sold 5,000 options to buy
@ $10.75, valued at
$53.8k
Disposed/sold 10,000 options to buy
@ $11.85, valued at
$118.5k
Disposed/sold 10,000 options to buy
@ $9.56, valued at
$95.6k
|
|
| 10/24/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/24/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/24/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/24/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/24/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/24/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/24/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/24/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/24/2013 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 10/24/2013 |
8-K
| Quarterly results |
| 10/24/2013 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 10/23/2013 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 10/15/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 10/10/2013 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 5% stake in OPTIMER PHARMACEUTICALS |
| 10/10/2013 |
SC 13G/A
| FMR LLC reports a 5.4% stake in OPTIMER PHARMACEUTICALS INC |
| 09/18/2013 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 09/18/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 09/18/2013 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
|
|
|